AtriCure, Inc. (ATRC)
Health Care ยท Surgical & Medical Instruments & Apparatus
AtriCure, Inc. (ATRC) is listed on Nasdaq, where its shares have traded since August 5, 2005. SentiSense covers AtriCure, Inc. in the Health Care sector, and its Standard Industrial Classification is Surgical & Medical Instruments & Apparatus. Michael H. Carrel is its chief executive officer. The company reports 1,350 employees, and its corporate website is www.atricure.com.
About AtriCure, Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Latest reported results
AtriCure, Inc. reported revenue of $154.4 million for Q3 FY2026, up 15.0% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 243 institutions reported holding ATRC, with 52.2 million shares worth $1.5 billion in aggregate. The largest reported holders were Vanguard, BlackRock and Wellington Management. Of the 5 largest reported holders, 3 added shares and 2 reduced their positions during the quarter.
More on ATRC
- ATRC sentiment: whether news and social coverage of AtriCure, Inc. leans bullish or bearish, and the stories driving it.
- ATRC ownership: all 243 reporting institutions, plus insider and congressional trades.
- ATRC financials: revenue, net income, operating margin and free cash flow through Q3 FY2026.
Frequently asked questions
What does AtriCure, Inc. do?
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors.
What sector is ATRC in?
SentiSense classifies AtriCure, Inc. in the Health Care sector, and its Standard Industrial Classification is Surgical & Medical Instruments & Apparatus.
Where does ATRC stock trade?
AtriCure, Inc. (ATRC) is listed on Nasdaq, where its shares have traded since August 5, 2005.
Who is the CEO of AtriCure, Inc.?
Michael H. Carrel is the chief executive officer of AtriCure, Inc..